A patient with suspected acute liver failure presents with worsening jaundice, confusion, and elevated ammonia levels. What is the priority nursing intervention to address the patient's hepatic encephalopathy?

A) Administer lactulose as prescribed to reduce ammonia levels.

B) Encourage increased fluid intake to prevent dehydration.

C) Implement seizure precautions to ensure patient safety.

D) Monitor blood glucose levels closely for hypoglycemia.

A patient with acute liver failure presents with new-onset confusion and elevated ammonia levels. Which of the following interventions should the nurse prioritize to address the patient's neurological symptoms?

A) Administer lactulose as prescribed

B) Prepare the patient for a CT scan of the brain

C) Initiate oxygen therapy to manage tachypnea

D) Administer vitamin K to correct coagulopathy

A patient with hepatic encephalopathy is being treated with lactulose. Despite some improvement in mental status, the patient's abdominal discomfort persists, jaundice has plateaued, and liver enzymes remain elevated. Given the current clinical findings, what is the nurse's priority intervention?

B) Monitor for signs of bleeding and prepare for potential administration of fresh frozen plasma.

A) Increase the dose of lactulose to further reduce ammonia levels.

B) Monitor for signs of bleeding and prepare for potential administration of fresh frozen plasma.

C) Administer intravenous fluids to manage dehydration and support liver function.

D) Educate the patient on the importance of maintaining a protein-restricted diet to reduce ammonia production.

A patient with hepatic encephalopathy is being treated with lactulose. In the first 24 hours, he shows modest improvement in mental status but persistent jaundice and abdominal discomfort. His ammonia levels have slightly improved, but his transaminase and bilirubin levels remain elevated. Given these findings, what should be the nurse's priority intervention?

B) Monitor neurological status frequently to assess for changes.

A) Encourage increased fluid intake to improve kidney function.

B) Monitor neurological status frequently to assess for changes.

C) Administer additional doses of lactulose to further decrease ammonia levels.

D) Prepare the patient for an immediate liver transplant evaluation.

A patient with progressive hepatic dysfunction and mild ascites is being considered for diuretic therapy. Which nursing intervention is most critical to perform before initiating diuretic treatment?

B) Assess the patient's electrolyte levels

A) Measure the patient's abdominal girth

B) Assess the patient's electrolyte levels

C) Monitor the patient's blood pressure

D) Evaluate the patient's daily fluid intake and output

A patient with worsening liver function presents with ascites, increased bilirubin levels, and fluctuating mental status. The healthcare team is considering the administration of diuretics to manage ascites. Which nursing intervention is most important to implement when administering diuretics in this patient to prevent complications?

A) Monitor serum electrolyte levels closely, particularly potassium.

B) Restrict fluid intake to 500 mL per day.

C) Administer diuretics only in the morning to prevent nocturia.

D) Encourage increased sodium intake to compensate for losses.

A patient with decompensated liver disease and ascites has been receiving low-dose diuretics. The patient's creatinine level has risen, indicating potential kidney injury, and they exhibit signs of hepatic encephalopathy. Which nursing intervention is most appropriate to prioritize at this time?

C) Initiate lactulose therapy to reduce ammonia levels.

A) Increase the diuretic dosage to enhance fluid removal.

B) Administer intravenous fluids to improve renal perfusion.

C) Initiate lactulose therapy to reduce ammonia levels.

D) Restrict fluid intake to prevent further ascites development.

A patient with decompensated liver disease is experiencing fatigue, confusion, and a rise in creatinine levels after starting low-dose diuretics for ascites. Which immediate intervention should the nurse prioritize to address the patient's current condition?

A) Administer a dose of lactulose to reduce ammonia levels.

B) Increase the diuretic dosage to enhance fluid removal.

C) Initiate a fluid restriction to manage hyponatremia.

D) Prepare the patient for a paracentesis to relieve abdominal distension.

A patient with decompensated liver disease exhibits increased lethargy, confusion, and mild asterixis, accompanied by elevated creatinine and altered electrolyte levels. Which nursing intervention is the priority in managing this patient’s condition?

A) Administering lactulose as prescribed to enhance ammonia clearance

B) Increasing diuretic dosage to manage persistent ascites

C) Initiating fluid restriction to address hyponatremia

D) Administering potassium supplements to correct hyperkalemia

Hep a - Nursing Case Study

Pathophysiology

• Primary mechanism: Hepatitis A virus (HAV) enters the body via the fecal-oral route, primarily affecting hepatocytes. The virus is taken up by the liver, where it replicates and causes direct cytopathic effects, leading to hepatocyte inflammation and necrosis.

• Secondary mechanism: The host immune response, particularly T-cell-mediated immunity, targets infected hepatocytes, exacerbating liver damage. This immune-mediated destruction is responsible for the majority of liver inflammation and contributes to the clinical manifestations of hepatitis.

• Key complication: While Hepatitis A is usually self-limiting, acute liver failure can occur in rare cases, characterized by rapid deterioration of liver function and potential life-threatening complications, such as encephalopathy and coagulopathy.

Patient Profile

Demographics:

32-year-old male, food service worker

History:

• Key past medical history: Mild asthma, no previous liver issues

• Current medications: Albuterol inhaler as needed

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Fatigue and abdominal pain

• Key symptoms: Jaundice, dark urine, nausea, reduced appetite

• Vital signs: Temperature 100.8°F, Heart rate 102 bpm, Blood pressure 110/70 mmHg, Respiratory rate 18 breaths per minute

Section 1

Change in Patient Status:

Over the next 48 hours, the patient's condition begins to evolve. Despite supportive care, including hydration and rest, his fatigue intensifies, and he becomes increasingly lethargic. His abdominal pain shifts from a dull ache to a more persistent discomfort, particularly in the right upper quadrant. The jaundice becomes more pronounced, with a deepening yellow hue to his skin and sclera. He also reports new-onset confusion and difficulty concentrating, which are concerning for potential hepatic encephalopathy. Vital signs show a slight increase in temperature to 101.2°F, heart rate of 110 bpm, blood pressure steady at 112/68 mmHg, but new tachypnea with a respiratory rate of 22 breaths per minute.

Laboratory tests reveal worsening liver function, with an elevation in transaminases (AST 1450 U/L, ALT 1780 U/L) and bilirubin levels (total bilirubin 5.8 mg/dL). Coagulation studies show an increased prothrombin time (PT 19 seconds) and decreased platelet count, raising concerns for coagulopathy. Ammonia levels are also elevated, correlating with his neurological symptoms. These changes suggest an acute deterioration in liver function, prompting the healthcare team to consider the possibility of acute liver failure. The team discusses the need for close monitoring in a higher level of care, considering the potential for rapid progression to life-threatening complications.

This change in status requires the healthcare team to reassess the patient's management plan urgently. The focus shifts to stabilizing his condition and preventing further deterioration. The plan involves initiating lactulose to manage the hepatic encephalopathy, considering vitamin K administration to address the coagulopathy, and preparing for potential transfer to a facility equipped for liver transplant evaluation, should his condition continue to decline. The team also emphasizes the importance of monitoring neurological status, liver function tests, and coagulation parameters closely to guide ongoing treatment decisions.

Section 2

Response to Interventions:

In the first 24 hours following the initiation of lactulose therapy, the patient shows a modest improvement in his mental status, with periods of increased alertness and slightly improved concentration. However, his abdominal discomfort persists, and his jaundice appears to have plateaued rather than improved. His vital signs remain stable, with a temperature of 100.8°F, heart rate at 108 bpm, blood pressure at 114/70 mmHg, and respiratory rate at 20 breaths per minute. These changes indicate a partial response to the interventions aimed at managing hepatic encephalopathy.

Repeat laboratory tests show a slight improvement in ammonia levels, dropping to 78 µmol/L from previously elevated values. However, transaminase levels remain high (AST 1400 U/L, ALT 1750 U/L), and bilirubin levels have increased to 6.2 mg/dL, suggesting ongoing liver inflammation and damage. Coagulation studies reveal a persistent prolongation of PT at 18 seconds, despite vitamin K administration, highlighting the liver's impaired synthetic function. The platelet count has further decreased, now at 95,000/µL, raising concerns for potential bleeding risks, especially with invasive procedures or worsening liver function.

The healthcare team decides to continue monitoring the patient closely, particularly for signs of bleeding or further neurological changes. They discuss the potential need for more aggressive interventions, such as the consideration of fresh frozen plasma if coagulopathy worsens. The team also plans for a repeat abdominal ultrasound to evaluate for ascites or changes suggestive of worsening hepatic architecture. The patient's partial response to lactulose offers some optimism, yet the persistent elevation in liver enzymes and bilirubin levels serve as a reminder of the fragile nature of his condition, necessitating ongoing vigilance and readiness to escalate care, including the potential for liver transplant evaluation.

Section 3

As the team continues to monitor the patient, a new complication arises. Over the next 48 hours, the patient develops mild ascites, confirmed by the repeat abdominal ultrasound. The ultrasound also reveals a slight increase in hepatic echogenicity, suggestive of ongoing liver inflammation. The presence of ascites signifies a progression in the patient's hepatic dysfunction, potentially indicating portal hypertension. Clinically, the patient reports increased abdominal distension and discomfort, which correlates with the ultrasound findings. His vital signs remain relatively stable, but his heart rate has increased slightly to 112 bpm, perhaps reflecting discomfort or a compensatory response to changes in intravascular volume status due to shifting fluid dynamics.

Laboratory tests show a further decline in liver function, with bilirubin levels rising to 7.4 mg/dL and transaminase levels remaining elevated (AST 1450 U/L, ALT 1800 U/L). The patient's INR has increased to 1.8 despite ongoing vitamin K supplementation, indicating a worsening coagulopathy. His platelet count has dropped further to 88,000/µL, heightening the risk of bleeding and warranting additional precautions. Ammonia levels remain stable, yet his mental status fluctuates, with periods of confusion interspersed with lucidity, underscoring the delicate balance achieved with lactulose therapy.

In light of these developments, the healthcare team deliberates on adjusting the treatment plan. The option of administering diuretics is considered to manage the ascites, but with caution due to the risk of exacerbating renal dysfunction or electrolyte imbalances. Fresh frozen plasma is prepared as a contingency for further coagulopathy correction before any invasive procedures. The team also revisits the idea of early referral for liver transplant evaluation, recognizing the potential for further deterioration. The patient's evolving condition requires careful assessment and nuanced decision-making to balance the management of existing complications against the risk of potential new issues, setting the stage for the next steps in his care journey.

Section 4

As the healthcare team moves forward with the patient's management, there is a cautious implementation of low-dose diuretics to address the ascites. Over the subsequent 24 hours, the patient shows some initial response with a slight reduction in abdominal distension, yet his urine output remains modest. However, new laboratory results reveal a concerning development. The patient's creatinine level has risen to 1.6 mg/dL from a baseline of 0.9 mg/dL, indicating a potential acute kidney injury secondary to diuretic use or progressing hepatic dysfunction. Electrolyte levels show a mild hyponatremia with a serum sodium of 130 mEq/L, necessitating further evaluation and adjustment in the diuretic regimen.

Clinically, the patient appears more fatigued and his confusion episodes become more pronounced. His vital signs show a mild hypotensive trend with a blood pressure reading of 98/60 mmHg, although his heart rate remains elevated at 114 bpm. This hemodynamic shift prompts the team to consider the delicate balance between managing fluid overload and preserving renal function. Given the rising creatinine and fluctuating mental status, there is a critical need to reassess the current treatment strategy to prevent further renal compromise and ensure adequate cerebral perfusion.

The team decides to halt the diuretics temporarily and prioritize fluid balance through careful monitoring of intake and output while considering albumin infusion to support oncotic pressure. Additionally, they intensify lactulose therapy to manage hepatic encephalopathy more effectively, aiming to stabilize the patient's mental status. As the patient's condition remains precarious, the team accelerates the process for liver transplant evaluation, recognizing the potential progression toward end-stage liver disease. These steps underscore the complexity of managing decompensated liver disease with multi-organ involvement, highlighting the need for continual re-evaluation in response to evolving clinical dynamics.

Section 5

As the healthcare team closely monitors the patient, they observe a significant change in his status over the next 48 hours. Despite the temporary cessation of diuretics and the initiation of albumin infusion, the patient's ascites persists, although it does not worsen. More concerningly, the patient's mental status deteriorates further, with increased lethargy and episodes of confusion that are now accompanied by mild asterixis, suggestive of worsening hepatic encephalopathy. In light of these developments, the team intensifies lactulose administration, ensuring frequent dosing to enhance ammonia clearance.

New diagnostic results reveal a further rise in creatinine to 2.0 mg/dL, solidifying the diagnosis of acute kidney injury likely secondary to hepatorenal syndrome. Serum sodium remains low at 128 mEq/L, while potassium levels are now slightly elevated at 5.2 mEq/L, indicating the need for careful electrolyte management. These laboratory findings, combined with the patient's hypotension and tachycardia, necessitate a delicate balancing act to maintain renal perfusion without exacerbating ascites or precipitating further electrolyte imbalances.

The team acknowledges the escalating complexity of the patient's condition and the looming risk of multi-organ failure. A multidisciplinary approach is reinforced, involving nephrology, hepatology, and critical care specialists to optimize the management plan. The accelerated liver transplant evaluation becomes increasingly urgent, as the potential for irreversible liver damage looms. This phase of the patient's journey underscores the intricate interplay between hepatic and renal function, demanding vigilant monitoring and adaptive strategies to navigate the challenges of decompensated liver disease.